Switch theme
Sign up to access all valuation multiples
Pro Medicus is a healthcare IT company specializing in radiology imaging software. Its main product, Visage 7, is a clinical desktop application that radiologists use to view, enhance, and manipulate images from any device and make a diagnosis. Its main customers are US private academic hospitals. In fiscal 2022, Pro Medicus earned 79% of revenue in North America, 16% from Australia, and the remaining 6% in Europe.
1983
76
LTM Revenue $127M
LTM EBITDA $97.0M
$13.9B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Pro Medicus has a last 12-month revenue of $127M and a last 12-month EBITDA of $97.0M.
In the most recent fiscal year, Pro Medicus achieved revenue of $101M and an EBITDA of $75.9M.
Pro Medicus expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Pro Medicus valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $78.4M | $101M | XXX | XXX | XXX |
| Gross Profit | $58.4M | $78.1M | XXX | XXX | XXX |
| Gross Margin | 74% | 77% | XXX | XXX | XXX |
| EBITDA | $57.6M | $75.9M | XXX | XXX | XXX |
| EBITDA Margin | 73% | 75% | XXX | XXX | XXX |
| Net Profit | $27.9M | $38.1M | XXX | XXX | XXX |
| Net Margin | 36% | 38% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Pro Medicus's stock price is AUD 213 (or $134).
Pro Medicus has current market cap of AUD 22.2B (or $14.0B), and EV of AUD 22.1B (or $13.9B).
See Pro Medicus trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $13.9B | $14.0B | XXX | XXX | XXX | XXX | $0.65 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Pro Medicus has market cap of $14.0B and EV of $13.9B.
Pro Medicus's trades at 109.1x LTM EV/Revenue multiple, and 143.0x LTM EBITDA.
Analysts estimate Pro Medicus's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Pro Medicus and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $13.9B | XXX | XXX | XXX |
| EV/Revenue | 117.9x | XXX | XXX | XXX |
| EV/EBITDA | 155.5x | XXX | XXX | XXX |
| P/E | 226.1x | XXX | XXX | XXX |
| P/E/Growth | 6.0x | XXX | XXX | XXX |
| EV/FCF | 241.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpPro Medicus's NTM/LTM revenue growth is 34%
Pro Medicus's revenue per employee for the last fiscal year averaged $1.3M, while opex per employee averaged $0.4M for the same period.
Over next 12 months, Pro Medicus's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Pro Medicus's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Pro Medicus and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 29% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 76% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 32% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 110% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $1.3M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.4M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 2% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 19% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 30% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Alcidion Group | XXX | XXX | XXX | XXX | XXX | XXX |
| CurveBeam AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Doctor Care Anywhere | XXX | XXX | XXX | XXX | XXX | XXX |
| Echo IQ | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Pro Medicus acquired XXX companies to date.
Last acquisition by Pro Medicus was XXXXXXXX, XXXXX XXXXX XXXXXX . Pro Medicus acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Pro Medicus founded? | Pro Medicus was founded in 1983. |
| Where is Pro Medicus headquartered? | Pro Medicus is headquartered in Australia. |
| How many employees does Pro Medicus have? | As of today, Pro Medicus has 76 employees. |
| Who is the CEO of Pro Medicus? | Pro Medicus's CEO is Dr. Sam Aaron Hupert, M.B.B.S.. |
| Is Pro Medicus publicy listed? | Yes, Pro Medicus is a public company listed on ASX. |
| What is the stock symbol of Pro Medicus? | Pro Medicus trades under PME ticker. |
| When did Pro Medicus go public? | Pro Medicus went public in 2000. |
| Who are competitors of Pro Medicus? | Similar companies to Pro Medicus include e.g. Benevolent AI, Alcidion Group, CurveBeam AI, Doctor Care Anywhere. |
| What is the current market cap of Pro Medicus? | Pro Medicus's current market cap is $14.0B |
| What is the current revenue of Pro Medicus? | Pro Medicus's last 12-month revenue is $127M. |
| What is the current EBITDA of Pro Medicus? | Pro Medicus's last 12-month EBITDA is $97.0M. |
| What is the current EV/Revenue multiple of Pro Medicus? | Current revenue multiple of Pro Medicus is 109.1x. |
| What is the current EV/EBITDA multiple of Pro Medicus? | Current EBITDA multiple of Pro Medicus is 143.0x. |
| What is the current revenue growth of Pro Medicus? | Pro Medicus revenue growth between 2023 and 2024 was 29%. |
| Is Pro Medicus profitable? | Yes, Pro Medicus is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
